Dementia risk prediction in the population: Are screening models accurate?

Nature Reviews Neurology

Volumn 6, Issue 6, 2010, Pages 318-326

  Stephan, Blossom C M ^a   Kurth, Tobias ^c   Matthews, Fiona E ^b   Brayne, Carol ^a   Dufouil, Carole ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HUMAN; MASS SCREENING; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE;

ANIMALS; COGNITION DISORDERS; DEMENTIA; DIAGNOSTIC TESTS, ROUTINE; HUMANS; MASS SCREENING; NEUROPSYCHOLOGICAL TESTS; POPULATION GROUPS; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77954862391     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.54     Document Type: Review

References (55)

1. Matthews, F. E., Stephan, B. C., Bond, J., McKeith, I. & Brayne, C. Operationalisation of mild cognitive impairment: a graphical approach. PLoS Med. 4, 1615-1619 (2007).
2. Petersen, R. C. et al. Current concepts in mild cognitive impairment. Arch. Neurol. 58, 1985-1992 (2001).
3. Levy, R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int. Psychogeriatr. 6, 63-68 (1994).
4. Winblad, B. et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256, 240-246 (2004).
5. Mitchell, A. J. & Shiri-Feshki, M. Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119, 252-265 (2009).
6. Matthews, F. E., Stephan, B. C., McKeith, I. G., Bond, J. & Brayne, C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J. Am. Geriatr. Soc. 56, 1424-1433 (2008).
7. Farias, S. T., Mungas, D., Reed, B. R., Harvey, D. & DeCarli, C. Progression of mild cognitive impairment to dementia in clinic-vs communitybased cohorts. Arch. Neurol. 66, 1151-1157 (2009).
8. Ganguli, M., Dodge, H. H., Shen, C. & DeKosky, S. T. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63, 115-121 (2004).
9. Stephan, B. C., Brayne, C., McKeith, I. G., Bond, J. & Matthews, F. E. Mild cognitive impairment in the older population: who is missed and does it matter? Int. J. Geriatr. Psychiatry 23, 863-871 (2008).
10. Matthews, F. et al. The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med. 2, e193 (2005).
11. Artero, S., Petersen, R., Touchon, J. & Ritchie, K. Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement. Geriatr. Cogn. Disord. 22, 465-470 (2006).
12. Baars, M. A. et al. Predictive value of mild cognitive impairment for dementia. The influence of case definition and age. Dement. Geriatr. Cogn. Disord. 27, 173-181 (2009).
13. Busse, A., Bischkopf, J., Riedel-Heller, S. G. & Angermeyer, M. C. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria: results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br. J. Psychiatry 182, 449-454 (2003).
14. Busse, A., Bischkopf, J., Riedel-Heller, S. G. & Angermeyer, M. C. Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol. Med. 33, 1029-1038 (2003). (Pubitemid 37009821)
15. Busse, A., Hensel, A., Gühne, U., Angermeyer, M. C. & Riedel-Heller, S. G. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 67, 2176-2185 (2006).
16. Ritchie, K., Artero, S. & Touchon, J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 56, 37-42 (2001). (Pubitemid 32059649)
17. Folstein, M. F., Folstein, S. E. & McHugh, P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198 (1975).
18. Busse, A., Bischkopf, J., Riedel-Heller, S. G. & Angermeyer, M. C. Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol. Scand. 108, 71-81(2003).
19. Bidzan, L., Pachalska, M. & Bidzan, M. Predictors of clinical outcome in MCI. Med. Sci. Monit. 13, CR398-CR405 (2007).
20. Palmer, K. et al. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68, 1596-1602 (2007).
21. Ravaglia, G. et al. Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement. Geriatr. Cogn. Disord. 21, 51-58 (2006).
22. Tabert, M. H. et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 58, 758-764 (2002).
23. Fleisher, A. S. et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 70, 191-199 (2008).
24. Hirao, K. et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 28, 1014-1021 (2005).
25. Kantarci, K. et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 72, 1519-1525 (2009).
26. McKelvey, R. et al. Lack of prognostic significance of SPECT abnormalities in nondemented elderly subjects with memory loss. Can. J. Neurol. Sci. 26, 23-28 (1999).
27. Herukka, S. K., Pennanen, C., Soininen, H. & Pirttilä, T. CSF A-42, tau and phosphorylated tau correlate with medial temporal lobe atrophy. J. Alzheimers Dis. 14, 51-57 (2008).
28. Hsiung, G. Y., Sadovnick, A. D. & Feldman, H. Apolipoprotein E -4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171, 863-867 (2004).
29. Hyman, B. T. et al. Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol. 40, 55-66 (1996).
30. Mattsson, N. et al. CSF Biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393 (2009).
31. Mitchell, A. J. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a metaanalysis of 51 studies. J. Neurol. Neurosurg. Psychiatry 80, 966-975 (2009).
32. Riemenschneider, M. et al. Cerebrospinal fluid tau and amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch. Neurol. 59, 1729-1734 (2002).
33. Tang, B. L. & Kumar, R. Biomarkers of mild cognitive impairment and Alzheimer's disease. Ann. Acad. Med. Singapore 37, 406-416 (2008).
34. Barnes, D. E. et al. Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology 73, 173-179 (2009).
35. Hensel, A., Angermeyer, M. C. & Riedel-Heller, S. G. Measuring cognitive change in older adults. Do reliable change indices of the SIDAM predict dementiA- J. Neurol. 254, 1359-1365 (2007). (Pubitemid 350112322)
36. Hensel, A. et al. Does a reliable decline in Mini Mental State Examination total score predict dementiA- Diagnostic accuracy of two reliable change indices. Dement. Geriatr. Cogn. Disord. 27, 50-58 (2009).
37. Holtzer, R., Verghese, J., Wang, C., Hall, C. B. & Lipton, R. B. Within-person acrossneuropsychological test variability and incident dementia. JAMA 300, 823-830 (2008).
38. Jorm, A. F., Masaki, K. H., Petrovitch, H., Ross, G. W. & White, L. R. Cognitive deficits 3 to 6 years before dementia onset in a population sample: the Honolulu-Asia aging study. J. Am. Geriatr. Soc. 53, 452-455 (2005).
39. Jungwirth, S. et al. Screening for Alzheimer's dementia at age 78 with short psychometric instruments. Int. Psychogeriatr. 21, 548-559 (2009).
40. Masur, D. M., Sliwinski, M., Lipton, R. B., Blau, A. D. & Crystal, H. A. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44, 1427-1432 (1994).
41. Nakata, E. et al. Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki-Tajiri project. Neuroepidemiology 33, 103-110 (2009).
42. Nielsen, H., Lolk, A., Andersen, K., Andersen, J. & Kragh-Sørensen, P. Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG. The Odense Study. Int. J. Geriatr. Psychiatry 14, 957-963 (1999).
43. Rapp, M. A. & Reischies, F. M. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). Am. J. Geriatr. Psychiatry 13, 134-141 (2005).
44. Tierney, M. C., Yao, C., Kiss, A. & McDowell, I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64, 1853-1859 (2005).
45. Kivipelto, M. et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 5, 735-741 (2006).
46. Mitnitski, A. et al. A vascular risk factor index in relation to mortality and incident dementia. Eur. J. Neurol. 13, 514-521 (2006).
47. Hogan, D. B. & Ebly, E. M. Predicting who will develop dementia in a cohort of Canadian seniors. Can. J. Neurol. Sci. 27, 18-24 (2000).
48. Jungwirth, S. et al. Prediction of Alzheimer dementia with short neuropsychological instruments. J. Neural Transm. 116, 1513-1521 (2009).
49. Palmer, K., Bäckman, L., Winblad, B. & Fratiglioni, L. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ 326, 245 (2003).
50. Waite, L. M., Broe, G. A., Grayson, D. A. & Creasey, H. Preclinical syndromes predict dementia: the Sydney older persons study. J. Neurol. Neurosurg. Psychiatry 71, 296-302 (2001).
51. Bäckman, L., Jones, S., Berger, A. K., Laukka, E. J. & Small, B. J. Multiple cognitive deficits during the transition to Alzheimer's disease. J. Intern. Med. 256, 195-204 (2004).
52. Wechsler, D. Manual for the Wechsler Adult Intelligence Scale-Revised (The Psychological Corporation, New York, 1981).
53. Barnes, D. E. et al. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: a framework for identifying individuals with a high dementia risk. Alzheimers Dement. 6, 138-141 (2010).
54. Cook, N. R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115, 928-935 (2007).
55. Cook, N. R. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin. Chem. 54, 17-23 (2008).